ATBPF - Antibe Therapeutics Inc. GAAP EPS of -$0.10 misses by $0.02 August, 15 2022 08:27 AM Antibe Therapeutics Antibe Therapeutics Inc. press release ( OTCQX:ATBPF ): Q1 GAAP EPS of -$0.10 misses by $0.02 . The Company had an available cash balance and term deposits totaling $50.2 million. For further details see: Antibe Therapeutics Inc. GAAP EPS of -$0.10 misses by $0.02